Sarli V - Search Results

1

Inhibition of the mitotic kinesin Eg5 up-regulates Hsp70 through the phosphatidylinositol 3-kinase/Akt pathway in multiple myeloma cells.

Liu M, Aneja R, Liu C, Sun L, Gao J, Wang H, Dong JT, Sarli V, Giannis A, Joshi HC, Zhou J. Liu M, et al. Among authors: sarli v. J Biol Chem. 2006 Jun 30;281(26):18090-7. doi: 10.1074/jbc.M601324200. Epub 2006 Apr 20. J Biol Chem. 2006. PMID: 16627469 Free article.

2

Targeting the kinesin spindle protein: basic principles and clinical implications.

Sarli V, Giannis A. Sarli V, et al. Clin Cancer Res. 2008 Dec 1;14(23):7583-7. doi: 10.1158/1078-0432.CCR-08-0120. Clin Cancer Res. 2008. PMID: 19047082 Review.

3

Synthesis and biological evaluation of new tetrahydro-beta-carbolines as inhibitors of the mitotic kinesin Eg5.

Sunder-Plassmann N, Sarli V, Gartner M, Utz M, Seiler J, Huemmer S, Mayer TU, Surrey T, Giannis A. Sunder-Plassmann N, et al. Among authors: sarli v. Bioorg Med Chem. 2005 Nov 15;13(22):6094-111. doi: 10.1016/j.bmc.2005.06.027. Epub 2005 Aug 3. Bioorg Med Chem. 2005. PMID: 16084101

4

Inhibitors of mitotic kinesins: next-generation antimitotics.

Sarli V, Giannis A. Sarli V, et al. ChemMedChem. 2006 Mar;1(3):293-8. doi: 10.1002/cmdc.200500045. ChemMedChem. 2006. PMID: 16892362 Review. No abstract available.

5

Selective inhibition of CBP/p300 HAT.

Sarli V, Giannis A. Sarli V, et al. Chem Biol. 2007 Jun;14(6):605-6. doi: 10.1016/j.chembiol.2007.06.001. Chem Biol. 2007. PMID: 17584607

6

Synthesis and biological evaluation of novel EG5 inhibitors.

Sarli V, Huemmer S, Sunder-Plassmann N, Mayer TU, Giannis A. Sarli V, et al. Chembiochem. 2005 Nov;6(11):2005-13. doi: 10.1002/cbic.200500168. Chembiochem. 2005. PMID: 16216042

7

Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cells.

Müller C, Gross D, Sarli V, Gartner M, Giannis A, Bernhardt G, Buschauer A. Müller C, et al. Among authors: sarli v. Cancer Chemother Pharmacol. 2007 Feb;59(2):157-64. doi: 10.1007/s00280-006-0254-1. Epub 2006 May 16. Cancer Chemother Pharmacol. 2007. PMID: 16703323

8

Synthesis and biological evaluation of SANT-2 and analogues as inhibitors of the hedgehog signaling pathway.

Büttner A, Seifert K, Cottin T, Sarli V, Tzagkaroulaki L, Scholz S, Giannis A. Büttner A, et al. Among authors: sarli v. Bioorg Med Chem. 2009 Jul 15;17(14):4943-54. doi: 10.1016/j.bmc.2009.06.008. Epub 2009 Jun 10. Bioorg Med Chem. 2009. PMID: 19541490

9

Synthesis of cyclopamine using a biomimetic and diastereoselective approach.

Giannis A, Heretsch P, Sarli V, Stössel A. Giannis A, et al. Among authors: sarli v. Angew Chem Int Ed Engl. 2009;48(42):7911-4. doi: 10.1002/anie.200902520. Angew Chem Int Ed Engl. 2009. PMID: 19591183 No abstract available.

10

Indeno[1,2-d]pyrido[1,2-a]pyrimidines: a new class of receptor tyrosine kinase inhibitors.

Tsanakopoulou M, Cottin T, Büttner A, Sarli V, Malamidou-Xenikaki E, Spyroudis S, Giannis A. Tsanakopoulou M, et al. Among authors: sarli v. ChemMedChem. 2008 Mar;3(3):429-33. doi: 10.1002/cmdc.200700306. ChemMedChem. 2008. PMID: 18181120 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters